Gujarat Magazine

Diabetic Retinopathy Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2036 – DelveInsight | Genentech, Ionis Pharma, AstraZeneca, Regenxbio, AbbVie, Palatin Techn

Diabetic Retinopathy Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2036 – DelveInsight | Genentech, Ionis Pharma, AstraZeneca, Regenxbio, AbbVie, Palatin Techn

The Key Diabetic Retinopathy Companies in the market include – Genentech, Ionis Pharmaceuticals, AstraZeneca, Regenxbio, AbbVie, Palatin Technologies, Avirmax Biopharma, Ocular Therapeutix, Inc., MingSight Pharmaceuticals, Inc, OcuTerra Therapeutics, Inc., RemeGen

Read Full Article

EGFR Non Small Cell Lung Cancer Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Astrazeneca, Bridge Biotherapeutics, Sichuan Kelun Pharma

(Albany, New York) – October 07, 2026: As per DelveInsight’s assessment, globally, EGFR Non Small Cell Lung Cancer pipeline constitutes 25+ key companies continuously working towards developing 30+ EGFR Non

Read Full Article

Diabetic Foot Ulcers Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation – DelveInsight | Topadur Pharma, Cynata Therapeutics, Transwell Biotech, Aposcience

The Key Diabetic Foot Ulcers Companies in the market incldue – Amniox (TissueTech), Topadur Pharma, Cynata Therapeutics, Transwell Biotech, Aposcience, Ilya Pharma, Microbion Corporation, MediWound, Paracrine, INC., NovaLead Pharma, and

Read Full Article

Neuroblastoma Market Analysis 2034: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | Y-mAbs Therapeutics, United Therapeutics Corp, EUSA Pharma, Clarity Pharma

The Key Neuroblastoma Companies in the market include – USWM (US WorldMeds), Y-mAbs Therapeutics, United Therapeutics Corporation, EUSA Pharma, Clarity Pharmaceuticals, Eli Lilly, Novartis, Athenex, Aptorum, K C Pharmaceuticals, Novartis,

Read Full Article

Inflammatory Bowel Disease Market Forecast 2036: Rising Demand, Novel Therapies, and Commercial Potential – DelveInsight | AbbVie, Janssen Pharma, Abivax, Morphic Therapeutic, Eli Lilly, Gilead

The Key Inflammatory Bowel Disease Companies in the market include – AbbVie, Janssen Pharmaceuticals, Abivax, Morphic Therapeutic, CJ Bioscience/4D Pharma, RedHill Biopharma, Tryp Therapeutics, Eli Lilly and Company, Gilead, Galapagos,

Read Full Article

Degenerative Disc Disease Pipeline 2026: Comprehensive Clinical Trials and Therapies Analysis with Key MOA and ROA Insights by DelveInsight | Mesoblast, DiscGenics, Biosplice Therapeutics, BIOPHARM

(Albany, New York) – October 07, 2026: As per DelveInsight’s assessment, globally, Degenerative Disc Disease pipeline constitutes 15+ key companies continuously working towards developing 15+ Degenerative Disc Disease treatment therapies,

Read Full Article

Chronic Smell and Flavor Loss Market Poised for Sustained Growth Amid Advancements in Treatment and Clinical Innovation – DelveInsight | Cyrano Therapeutics

(Albany, New York) – October 07, 2026: The Key Chronic Smell and Flavor Loss Companies in the market include – Cyrano Therapeutics, and others.   DelveInsight’s “Chronic Smell and Flavor

Read Full Article

Cerebral Palsy Market Analysis 2036: Industry Trends, Market Size, and Emerging Therapeutic Developments – DelveInsight | Neurocrine Biosciences, Teva Pharma, Bundang CHA Hospital, Jazz Pharma

(Albany, New York) – October 07, 2026: The Key Cerebral Palsy Companies in the market include – Ipsen, Abbvie (Allergan), Supernus Pharmaceuticals, Neurocrine Biosciences, Teva Pharmaceuticals, Bundang CHA Hospital, Jazz

Read Full Article

Focal Segmental Glomerulosclerosis Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2036 – DelveInsight | Retrophin, AbbVie, AstraZeneca, Pfizer, Sanofi, Teva

(Albany, New York) – October 07, 2026: The Key Focal Segmental Glomerulosclerosis Companies in the market include – Evergreen Therapeutics,

Read Full Article

Alpha Thalassemia Market Forecast 2036: Rising Demand, Novel Therapies, and Commercial Potential – DelveInsight | Forma Therapeutics, Genmedicon Biopharma, Bristol-Myers Squibb, Agios Pharma

(Albany, New York) – October 07, 2026: The Key Alpha Thalassemia Companies in the market include – Forma Therapeutics, Inc.,

Read Full Article

Idiopathic Membranous Nephropathy (IMN) Market Set to Grow from USD 130 Million in 2025 to USD 1,000 Million by 2036 as First Targeted Therapies AdvanceIdiopathic Membranous Nephropathy (IMN) Market

(Albany, New York) – October 07, 2026 – DelveInsight’s “Idiopathic Membranous Nephropathy – Market Insights, Epidemiology, and Market Forecast – 2036”

Read Full Article

Neuropathic Pain Market Poised for Major Change Through 2032 as Pipeline Therapies AdvanceNeuropathic Pain Market

(Albany, New York) – October 07, 2026 – DelveInsight’s “Neuropathic Pain – Market Insights, Epidemiology, and Market Forecast – 2032” report

Read Full Article

Structural Heart Devices Market Insights and Competitive Analysis: Growth Drivers, Segment Trends, and Regional Outlook Through 2034

Key Structural Heart Devices companies such as Medtronic, Boston Scientific Corporation, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, Valcare

Read Full Article

Non-Postoperative Pain Management Market is Projected to Grow by 2036 Owing to the Shift Toward Non-opioid Therapies and Advances in Rapid-Acting Pain Treatments | DelveInsight

The market dynamics for Non-Postoperative Pain Management are witnessing steady growth driven by the high and recurring burden of acute

Read Full Article

Complex Regional Pain Syndrome Market is Projected to Grow by 2036 Owing to Rising Chronic Pain Burden and Advances in Targeted Treatment Approaches | DelveInsight

The market dynamics for Complex Regional Pain Syndrome are witnessing steady growth driven by the rising burden of chronic pain,

Read Full Article

Rare NRG1 Fusion Market is Projected to Grow by 2034 Owing to the Advancement of Tumor-Agnostic Therapies and Precision Medicine | DelveInsight

The market dynamics for Rare NRG1 Fusion are witnessing steady growth driven by the increasing adoption of precision medicine, rising

Read Full Article

Psoriasis Market Outlook Through 2034: Growth Driven by Advances in Biologic and Oral Therapies

(Albany, New York) – October 07, 2026 – DelveInsight’s “Psoriasis Market Insights, Epidemiology, and Market Forecast-2034” report offers an in-depth understanding

Read Full Article

Genome Editing Market to Grow at a CAGR of 13.19% Through 2032, Driven by Rising Genetic Disorders, Advancements in CRISPR Technologies, and Strategic Activities

Key Genome Editing companies such as CRISPR Therapeutics, Thermo Fisher Scientific Inc., Editas Medicine, Revvity Discovery Limited, Biocompare, CrisprBits, GenAhead

Read Full Article

Giant Cell Arteritis Market Set for Significant Growth Through 2034 Driven by Advancing Therapies, Rising Diagnosed Cases, and Expanding Treatment Landscape | DelveInsight

(Albany, New York) – October 07, 2026 – DelveInsight’s “Giant Cell Arteritis Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an

Read Full Article

Osteoporosis Market to Witness Significant Growth Through 2036 Driven by Emerging Therapies, Expanding Treatment Landscape, and Rising Disease Burden | DelveInsight

(Albany, New York) – October 07, 2026 – DelveInsight’s “Osteoporosis Market Insights, Epidemiology, and Market Forecast – 2036” report offers an

Read Full Article

Recent Posts

Diabetic Retinopathy Market to Expand Rapidly with Advancing Pipeline and Increasing Treatment Adoption by 2036 – DelveInsight | Genentech, Ionis Pharma, AstraZeneca, Regenxbio, AbbVie, Palatin Techn

Read Full Article

Categories